Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,294 | -11,952 | -45,343 | -37,820 | -24,575 |
| Depreciation Amortization | 40 | 336 | 2,228 | 1,563 | 1,018 |
| Other Working Capital | 10,390 | 10,407 | -833 | 3,286 | 3,476 |
| Other Operating Activity | 1,264 | 619 | 2,062 | 1,454 | 845 |
| Operating Cash Flow | $-12,600 | $-590 | $-41,886 | $-31,517 | $-19,236 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -38,702 | -36,926 | 48,707 | 45,589 | 24,524 |
| PPE Investments | -3,626 | -1,246 | -1,462 | -343 | 73 |
| Investing Cash Flow | $-42,328 | $-38,172 | $47,245 | $45,246 | $24,597 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -171 | -66 | -66 | 0 | N/A |
| Common Stock Issued | 57,685 | 49,562 | 5,516 | 4,533 | 1,520 |
| Other Financing Activity | 0 | 0 | 1 | 0 | 0 |
| Financing Cash Flow | $57,514 | $49,496 | $5,451 | $4,533 | $1,520 |
| Beginning Cash Position | 13,146 | 13,146 | 2,336 | 2,336 | 2,336 |
| End Cash Position | 15,732 | 23,880 | 13,146 | 20,598 | 9,217 |
| Net Cash Flow | $2,586 | $10,734 | $10,810 | $18,262 | $6,881 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,600 | -590 | -41,886 | -31,517 | -19,236 |
| Capital Expenditure | -3,641 | -1,246 | -1,641 | -522 | -96 |
| Free Cash Flow | -16,241 | -1,836 | -43,527 | -32,039 | -19,332 |